Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.

MLA

Cooley, Lauren Folgosa, et al. “Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.” The Journal of Urology, vol. 206, no. 5, Nov. 2021, pp. 1147–56. EBSCOhost, https://doi.org/10.1097/JU.0000000000001937.

APA

Cooley, L. F., Emeka, A. A., Meyers, T. J., Cooper, P. R., Lin, D. W., Finelli, A., Eastham, J. A., Logothetis, C. J., Marks, L. S., Vesprini, D., Goldenberg, S. L., Higano, C. S., Pavlovich, C. P., Chan, J. M., Morgan, T. M., Klein, E. A., Barocas, D. A., Loeb, S., Helfand, B. T., … Catalona, W. J. (2021). Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort. The Journal of Urology, 206(5), 1147–1156. https://doi.org/10.1097/JU.0000000000001937

Chicago

Cooley, Lauren Folgosa, Adaeze A Emeka, Travis J Meyers, Phillip R Cooper, Daniel W Lin, Antonio Finelli, James A Eastham, et al. 2021. “Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.” The Journal of Urology 206 (5): 1147–56. doi:10.1097/JU.0000000000001937.